Khambata-Ford et al. analyzed the gene expression profile of 110 patients with colorectal cancer treated with Cetuximab to identify genes that were expressed differentially between the disease control group and the non-responders, demonstrated that AREG and EREG expression was associated with progression-free survival [10]. Here, AREG is linked to colorectal cancer.